Cancers (Aug 2023)

Locoregional Treatment in Intrahepatic Cholangiocarcinoma: Which Treatment for Which Patient?

  • Héloïse Bourien,
  • Chiara Carlotta Pircher,
  • Boris Guiu,
  • Angela Lamarca,
  • Juan W Valle,
  • Monica Niger,
  • Julien Edeline

DOI
https://doi.org/10.3390/cancers15174217
Journal volume & issue
Vol. 15, no. 17
p. 4217

Abstract

Read online

For unresectable intrahepatic cholangiocarcinoma (iCC), different locoregional treatments (LRT) could be proposed to patients, including radiofrequency ablation (RFA) and microwave ablation (MWA), external beam radiotherapy (EBRT) or transarterial treatments, depending on patient and tumor characteristics and local expertise. These different techniques of LRT have not been compared in a randomized clinical trial; most of the relevant studies are retrospective and not comparative. The aim of this narrative review is to help clinicians in their everyday practice discuss the pros and cons of each LRT, depending on the individual characteristics of their patients.

Keywords